Literature DB >> 1728986

Inflammatory cytokines.

A Cerami1.   

Abstract

The immune system produces cytokines and other humoral factors to protect the host when threatened by inflammatory agents, microbial invasion, or injury. In some cases this complex defense network successfully restores normal homeostasis, but at other times the overproduction of immunoregulatory mediators may actually prove deleterious to the host. Some examples of immune system-mediated injury have been extensively investigated including anaphylactic shock, autoimmune disease, and immune complex disorders. More recently it has become clear that the cytokine cachectin/tumor necrosis factor (TNF) occupies a key role in the pathophysiology associated with diverse inflammatory states and other serious illnesses including septic shock and cachexia. For example, when cachectin/TNF is produced by resident macrophages during early microbial infection, it mediates an inflammatory response that may alienate and repel the attacking organisms. If the infection spreads, however, the subsequent release of large quantities of cachectin/TNF into the circulation may be catastrophic and trigger a state of lethal shock. These toxic effects occur by direct action of TNF on host cells and by the interaction with a cascade of other endogenous mediators including interleukin-1 and interferon-gamma. The biology of cachectin/TNF will be reviewed, along with the potential for modulating the effects of this pluripotent molecule in a variety of pathologic states.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728986     DOI: 10.1016/0090-1229(92)90035-m

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  51 in total

Review 1.  Role of cytokines in testicular function.

Authors:  D B Hales; T Diemer; K H Hales
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

2.  TNF-alpha induced altered signaling mechanism in human neutrophil.

Authors:  S Das; S Bhattacharyya; S Ghosh; S Majumdar
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

3.  Production of polyclonal antibodies to feline tumor necrosis factor.

Authors:  C M Otto; F Niagro; R A McGraw; C A Rawlings
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Effects of C5a and FMLP on interleukin-8 production and proliferation of human umbilical vein endothelial cells.

Authors:  H Langeggen; E Johnson; G Hetland
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

5.  Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.

Authors:  M Segura; J Stankova; M Gottschalk
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome.

Authors:  H Zheng; C Ye; M Segura; M Gottschalk; J Xu
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

7.  Bacterial endotoxin lipopolysaccharide and reactive oxygen species inhibit Leydig cell steroidogenesis via perturbation of mitochondria.

Authors:  John A Allen; Thorsten Diemer; Paul Janus; Karen Held Hales; Dale B Hales
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

8.  Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice.

Authors:  Biana Godin; Ciro Chiappini; Srimeenakshi Srinivasan; Jenolyn F Alexander; Kenji Yokoi; Mauro Ferrari; Paolo Decuzzi; Xuewu Liu
Journal:  Adv Funct Mater       Date:  2012-10-23       Impact factor: 18.808

Review 9.  Are cytokines possible mediators of cancer cachexia?

Authors:  Y Noguchi; T Yoshikawa; A Matsumoto; G Svaninger; J Gelin
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

10.  Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin.

Authors:  J A Ember; S D Sanderson; T E Hugli; E L Morgan
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.